NYSEARCA:IBRN iShares Neuroscience and Healthcare ETF (IBRN) Price, Holdings, & News $29.98 -0.33 (-1.07%) As of 03:48 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsRatings About iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IBRN alerts:Sign Up Key Stats Today's Range$29.97▼$30.0350-Day Range$30.30▼$40.6752-Week Range$27.67▼$43.01Volume545 shsAverage Volume2,284 shsMarket Capitalization$6.00 millionAssets Under Management$6.05 millionDividend Yield1.07%Net Expense Ratio0.47%Aggregate RatingModerate Buy ETF Overview The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock. Read More iShares Neuroscience and Healthcare ETF ExpensesTypeIBRNTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.47%0.57%0.57%0.50%0.53%Other Expenses0.00%0.57%0.53%0.60%0.54%Total Expense0.47%0.72%0.75%0.75%0.73%Fee Waiver0.00%-0.72%-0.67%-0.78%-0.68%Net Expense0.47%0.60%0.63%0.57%0.60% Receive IBRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Neuroscience and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IBRN ETF News HeadlinesiShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Stock Price Down 3.6% - Here's WhyOctober 14 at 2:21 AM | americanbankingnews.comBlackRock, Inc. Expands Holdings in iShares Neuroscience and Healthcare ETFJanuary 8, 2025 | gurufocus.comSee More Headlines IBRN ETF - Frequently Asked Questions How have IBRN shares performed this year? iShares Neuroscience and Healthcare ETF's stock was trading at $32.32 at the beginning of the year. Since then, IBRN shares have decreased by 6.9% and is now trading at $30.10. How do I buy shares of iShares Neuroscience and Healthcare ETF? Shares of IBRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssueriShares Fund NameiShares Neuroscience and Healthcare ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IBRN Inception Date8/24/2022 Fund ManagerJennifer Hsui, Greg Savage, Paul Whitehead, Amy Whitelaw WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE FactSet Global Neuro Biopharma and MedTech Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings80 Fund Statistics Assets Under Management$6.05 million Average Daily Volume$0.00 Discount/Premium0.03% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerFlow Traders Options OptionableN/A Short Interest7,200 shs Miscellaneous Outstanding Shares200,000Beta0.80 Creation Unit50,000 Creation Fee$350.00 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report Top 10 IBRN HoldingsBiogen (NASDAQ:BIIB)Holding Weight: 4.86%Edgewise Therapeutics (NASDAQ:EWTX)Holding Weight: 4.47%Neurocrine Biosciences (NASDAQ:NBIX)Holding Weight: 4.46%PTC Therapeutics (NASDAQ:PTCT)Holding Weight: 4.43%Alkermes (NASDAQ:ALKS)Holding Weight: 4.27%argenex (NASDAQ:ARGX)Holding Weight: 3.90%Dianthus Therapeutics (NASDAQ:DNTH)Holding Weight: 3.74%Scholar Rock (NASDAQ:SRRK)Holding Weight: 3.74%Praxis Precision Medicines (NASDAQ:PRAX)Holding Weight: 3.67%Supernus Pharmaceuticals (NASDAQ:SUPN)Holding Weight: 3.56%Full Holdings DetailsIBRN Sector ExposureIBRN Industry Exposure This page (NYSEARCA:IBRN) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredElon's next millionaires start October 24?SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredTrump To Relaunch USD?President Trump's summit with Xi Jinping drew headlines for tariffs and trade truces, but the real story may b...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
